These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21305445)

  • 1. [A short-term diagnostic and economic impact model of neonatal screening for cystic fibrosis].
    Rasch A; Perleth M
    Klin Padiatr; 2011 Mar; 223(2):96-103. PubMed ID: 21305445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the costs of diagnosing cystic fibrosis with a newborn screening program.
    Lee DS; Rosenberg MA; Peterson A; Makholm L; Hoffman G; Laessig RH; Farrell PM
    J Pediatr; 2003 Jun; 142(6):617-23. PubMed ID: 12838188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the cost of cystic fibrosis diagnosis and treatment.
    Rosenberg MA; Farrell PM
    J Pediatr; 2005 Sep; 147(3 Suppl):S101-5. PubMed ID: 16202771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic implications of newborn screening for cystic fibrosis: a cost of illness retrospective cohort study.
    Sims EJ; Mugford M; Clark A; Aitken D; McCormick J; Mehta G; Mehta A;
    Lancet; 2007 Apr; 369(9568):1187-95. PubMed ID: 17416263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Implementation of the neonatal cystic fibrosis screening program in Switzerland: beginning January 2011].
    Mornand A; Barben J; Hafen G
    Rev Med Suisse; 2011 Feb; 7(283):456, 458-60. PubMed ID: 21452515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal screening for cystic fibrosis: an economic analysis.
    Nielsen R; Gyrd-Hansen D
    Health Econ; 2002 Jun; 11(4):285-99. PubMed ID: 12007162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost-effectiveness of prenatal carrier screening for cystic fibrosis.
    Lieu TA; Watson SE; Washington AE
    Obstet Gynecol; 1994 Dec; 84(6):903-12. PubMed ID: 7970468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of sweat testing for older siblings of patients with cystic fibrosis identified by newborn screening.
    Munck A; Houssin E; Roussey M
    J Pediatr; 2009 Dec; 155(6):928-930.e1. PubMed ID: 19914431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Low-Cost and Simple Genetic Screening for Cystic Fibrosis Provided by the Brazilian Public Health System.
    Rispoli T; Martins de Castro S; Grandi T; Prado M; Filippon L; Dornelles da Silva CM; Vargas JE; Rossetti LMR
    J Pediatr; 2018 Aug; 199():272-277.e3. PubMed ID: 29731357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of 4 neonatal screening strategies for cystic fibrosis.
    van den Akker-van Marle ME; Dankert HM; Verkerk PH; Dankert-Roelse JE
    Pediatrics; 2006 Sep; 118(3):896-905. PubMed ID: 16950979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [National program for neonatal screening for cystic fibrosis: implementation and preliminary results].
    Navarro J; Grosskopf C; Vidailhet M; Briard ML; Farriaux JP
    J Gynecol Obstet Biol Reprod (Paris); 2003 Feb; 32(1 Suppl):1S56-60. PubMed ID: 12592165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for implementation of cystic fibrosis newborn screening programs: Cystic Fibrosis Foundation workshop report.
    Comeau AM; Accurso FJ; White TB; Campbell PW; Hoffman G; Parad RB; Wilfond BS; Rosenfeld M; Sontag MK; Massie J; Farrell PM; O'Sullivan BP;
    Pediatrics; 2007 Feb; 119(2):e495-518. PubMed ID: 17272609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newborn screening for cystic fibrosis. The Cystic Fibrosis Neonatal Screening Study Group.
    Farrell PM; Mischler EH
    Adv Pediatr; 1992; 39():35-70. PubMed ID: 1442316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newborn screening for cystic fibrosis.
    Rock MJ
    Clin Chest Med; 2007 Jun; 28(2):297-305. PubMed ID: 17467549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neonatal screening for cystic fibrosis].
    Marchac V
    Soins Pediatr Pueric; 2004 Jun; (218):21-2. PubMed ID: 15327070
    [No Abstract]   [Full Text] [Related]  

  • 16. The Use of Economic Evaluation to Inform Newborn Screening Policy Decisions: The Washington State Experience.
    Grosse SD; Thompson JD; Ding Y; Glass M
    Milbank Q; 2016 Jun; 94(2):366-91. PubMed ID: 27265561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Policy issues for expanding newborn screening programs: the cystic fibrosis newborn screening experience in the United States.
    Wilfond BS; Gollust SE
    J Pediatr; 2005 May; 146(5):668-74. PubMed ID: 15870672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.
    Sermet-Gaudelus I; Roussel D; Bui S; Deneuville E; Huet F; Reix P; Bellon G; Lenoir G; Edelman A
    BMC Pediatr; 2006 Oct; 6():25. PubMed ID: 17018149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [French guidelines for sweat test practice and interpretation for cystic fibrosis neonatal screening].
    Sermet-Gaudelus I; Munck A; Rota M; Roussey M; Feldmann D; Nguyen-Khoa T;
    Arch Pediatr; 2010 Sep; 17(9):1349-58. PubMed ID: 20719482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. More evidence to favour newborn screening for cystic fibrosis.
    Wilcken B; Gaskin K
    Lancet; 2007 Apr; 369(9568):1146-7. PubMed ID: 17416243
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.